Table 5 Comparison of clinical characteristics between EGFR low and high expression groups.

From: Caveolin-1 inhibits the proliferation and invasion of lung adenocarcinoma via EGFR degradation

Clinical characteristics

EGFR low expression group (n = 27)

EGFR high expression group (n = 62)

χ2

P value

Age (years)

  

0.985

0.321

≤50

4

15

  

 >50

23

47

  

Gender

  

0.068

0.795

 Male

14

34

  

 Female

13

28

  

Pathological grade

  

0.203

0.653

 1–2

20

43

  

3

7

19

  

T grade

  

< 0.001

1

 T1-2

24

55

  

 T3-4

3

7

  

N grade

  

2.474

0.116

 N0

20

35

  

 N1-3

7

27

  

Clinical stage

  

1.304

0.253

 I-II

23

46

  

 III-IV

4

16

  
Back to article page